Contact Us  |  Search  
 
The National Academies of Sciences, Engineering and Medicine
Partnerships for Enhanced Engagement in Research
Development, Security, and Cooperation
Policy and Global Affairs
Home About Us For Grant Recipients Funded Projects Email Updates
PARTNERSHIPS FOR ENHANCED ENGAGEMENT IN RESEARCH (PEER)
Women in Science Mentoring Program (2020)


“Bridging the Gaps”: Understanding the barriers and facilitators in the tuberculosis prevention care cascade for optimizing isoniazid preventive therapy uptake among adults living with HIV in India, a mixed-method approach

PI: Neetal Nevrekar,  Byramjee Jeejeebhoy Government Medical College (BJGMC) - Johns Hopkins Clinical Research Site in Pune, India 
Project Dates: February 2022 - February 2024

Project Overview

India accounts for 26% of the TB cases worldwide and almost 40% of its population is infected with latent TB.  India ranks third in the share of HIV burden and has an estimated 71000 incident HIV-TB co-infection cases.  Nearly 25% of all deaths among PLHIV in India were estimated to be due to TB.  Prevention of TB disease is a critical component of the National Strategic Plan for TB elimination in India.  Hence, scaling up the IPT would be an excellent strategy to accelerate the rate of decline in TB incidence in India. India managed to rollout nationwide IPT policy only recently in 2017.  The IPT implementation in India has been challenging and coverage has been low.  Though India could achieve 95% ART coverage in 2019 for PLHIV co-infected with TB, the IPT coverage among eligible PLHIV was only 43-45%. 

The IPT policy has achieved limited success in low and middle-income countries.  With limited empirical research exploring the barriers to suboptimal IPT uptake, it is important to understand this knowledge gap.  Also, limited programmatic strategies exist to address this problem.  Therefore, studying the barriers to and facilitators for IPT uptake would serve public health for prevention of TB among adult PLHIV in India and similar HIV-TB burdened settings.  Dissemination of this evidence will help to identify strategies and devise targeted interventions to enhance IPT uptake.  As newer TB preventive regimens are being planned, this study could serve as a reference for their successful implementation in near future. 

As outlined in the WHO End TB Strategy, it is critical to address the HIV/TB co-infection to reduce the morbidity and mortality associated it.  With far reaching consequences of COVID-19 pandemic on health priorities, preventing TB in PLHIV forms the backbone of the national, regional and international response to combat the triple threat.  To scale up the IPT uptake among PLHIV, it is essential to understand the challenges and the motivational factors in TB prevention care cascade.  This research project can help translate the commitments made at the United Nations high-level meeting of the General Assembly on TB research into action by generating new scientific evidence which could guide policies and operational strategies to strengthen the care cascade for optimizing the IPT uptake. 

The project will investigate the barriers to IPT uptake among adult PLHIV and identify possible strategies (facilitators) to improve the uptake of IPT. This study will be conducted at Byramjee Jeejeebhoy Government Medical College (BJGMC)-Johns Hopkins Clinical Research Site in Pune, India, and this research project will be conducted under one of the ongoing HIV studies.
 
Back to WSMP Grant Recipients